The system was used for treatment.A batch record review of kit lot d346 was performed.There were no nonconformances related to the complaint.This lot met release requirements.The uvadex lot number was not provided as it was not administered.However, a review of all uvadex lots manufactured since january 2013 was performed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint categories, alarm #17: return pressure, alarm #18: system pressure, kit installation/removal failure, and clot observed.No trends were detected.This assessment is based on information available at the time of the investigation.No product was returned by the customer for investigation; therefore, it could not be determined if this specific product met specification.However, the customer reported that they did not spike the anticoagulant and saline bags correctly.Thus, the treatment was not properly anticoagulated and a clot formed.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).
|